155 results
Page 3 of 8
8-K
EX-3.1
i4lu5 2v8cr1
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-4.1
bgkzas0zcu5vj2qv
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-4.1
8n08il3hex4d96
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
rydlgvj1m6a2st5b1g9
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.2
b7z1usp1i0avojf4 jt7
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.2
g30p9obyis0nv4n
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K/A
EX-99.1
nm024km jwqx6lepydn
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K
EX-10.1
drflqp5
20 Apr 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.2
uy40awzw 42hil
20 Apr 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
z6ead
22 Sep 20
Entry into a Material Definitive Agreement
12:00am
DEFM14C
bktmgtz5 de
31 Aug 20
Information related to merger
7:00am
8-K/A
EX-99.1
x9pd2v68k
19 Aug 20
Report of Independent Registered Public Accounting Firm
5:06pm
PREM14C
vcbs kszfv
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
EX-10.5
d7ftxhmawik9
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.6
9m1qnt
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
m1z2poca6zg56pq
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.2
bq1vplnr
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.1
42n21y7npgh k461ar
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
SC 14F1
eo3ov663
8 Jun 20
Statement regarding change in majority of directors
11:05am